Ikarian Capital, LLC - ASLAN PHARMACEUTICALS LTD ownership

ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 2 filers reported holding ASLAN PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of ASLAN PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2022$151,446
+3.7%
820,4550.0%0.04%
+27.6%
Q3 2022$146,000
-21.1%
820,455
-15.5%
0.03%
-14.7%
Q2 2022$185,000
-3.6%
970,7470.0%0.03%
+36.0%
Q1 2022$192,000
+2.7%
970,747
+5.8%
0.02%
-10.7%
Q4 2021$187,000
-35.1%
917,348
-35.3%
0.03%
+40.0%
Q3 2021$288,000
+16.1%
1,417,348
+15.7%
0.02%0.0%
Q2 2021$248,000
+2.1%
1,224,5160.0%0.02%
+150.0%
Q1 2021$243,000
-40.0%
1,224,516
-39.0%
0.01%
-55.6%
Q4 2020$405,0002,006,4510.02%
Other shareholders
ASLAN PHARMACEUTICALS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,017,971$2,066,0000.49%
DAFNA Capital Management LLC 117,682$239,0000.08%
Temasek Holdings (Private) Ltd 1,422,475$2,888,0000.02%
PLATINUM INVESTMENT MANAGEMENT LTD 415,450$843,0000.02%
Virtu Financial LLC 54,386$110,0000.01%
MARSHALL WACE, LLP 96,095$195,0000.00%
UBS Group AG 150$00.00%
DEUTSCHE BANK AG\ 2,151$4,0000.00%
MORGAN STANLEY 18,582$37,0000.00%
BANK OF MONTREAL /CAN/ 10,000$20,0000.00%
View complete list of ASLAN PHARMACEUTICALS LTD shareholders